Portable Paper‐Based Nucleic Acid Enrichment for Field Testing
Advanced Science · 2023
DOI: 10.1002/advs.202205217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Junyang Mei und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Sh…. Hauptthemen laut MEDLINE: COVID-19, Nucleic Acids, Communicable Diseases. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Shanghai Municipal Health Commission, Medical Transformation Crossing Funding from Shanghai Jiao Tong University.
Abstract (Originalsprache)
Point‐of‐care testing (POCT) can be the method of choice for detecting infectious pathogens; these pathogens are responsible for not only infectious diseases such as COVID‐19, but also for certain types of cancers. For example, infections by human papillomavirus (HPV) or Helicobacter pylori (H. pylori) are the main cause of cervical and stomach cancers, respectively. COVID‐19 and many cancers are treatable with early diagnoses using POCT. A variety of nucleic acid testing have been developed for use in resource‐limited environments. However, questions like unintegrated nucleic acid extraction, open detection systems increase the risk of cross‐contamination, and dependence on expensive equipment and alternating current (AC) power supply, significantly limit the application of POCT, especially for on‐site testing. In this paper, a simple portable platform is reported capable of rapid sample‐to‐answer testing within 30 min based on recombinase polymerase amplification (RPA) at a lower temperature, to detect SARS‐CoV‐2 virus and H. pylori bacteria with a limit of detection as low as 4 × 10 2 copies mL −1 . The platform used a battery‐powered portable reader for on‐chip one‐pot amplification and fluorescence detection, and can test for multiple (up to four) infectious pathogens simultaneously. This platform can provide an alternative method for fast and reliable on‐site diagnostic testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China.
- Central Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
- CAS Key Laboratory of Nano-Bio Interface, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou, 215123, China.
ORCID-Profile: Peifeng Liu
Förderung
- National Natural Science Foundation of China
- Foundation of Shanghai Municipal Health Commission
- Medical Transformation Crossing Funding from Shanghai Jiao Tong University
- Innovative Research Team of High-level Local Universities in Shanghai
- Base and Talent Program of Tibet Autonomous Region
- Own Funds from the Suzhou Institute of Nano-Tech and Nano-Bionics
Zitieren
APA
Mei, J., Wang, D., Zhang, Y., Wu, D., Cui, J., Gan, M., & Liu, P. (2023). Portable Paper‐Based Nucleic Acid Enrichment for Field Testing. Advanced Science. https://doi.org/10.1002/advs.202205217
Vancouver
Mei J, Wang D, Zhang Y, Wu D, Cui J, Gan M, et al. Portable Paper‐Based Nucleic Acid Enrichment for Field Testing. Advanced Science. 2023. doi:10.1002/advs.202205217
BibTeX
@article{Mei2023,
author = {Mei, Junyang and Wang, Dandan and Zhang, Yiheng and Wu, Dan and Cui, Jinhui and Gan, Mingzhe and Liu, Peifeng},
title = {Portable Paper‐Based Nucleic Acid Enrichment for Field Testing},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202205217}
}
EUVIMED